Distributed automated manufacturing of pluripotent stem cell products

Establishing how to effectively manufacture cell therapies is an industry-level problem. Decentralised manufacturing is of increasing importance, and its challenges are recognised by healthcare regulators with deviations and comparability issues receiving specific attention from them. This paper is...

Descripción completa

Detalles Bibliográficos
Autores principales: Shariatzadeh, Maryam, Chandra, Amit, Wilson, Samantha L, McCall, Mark J, Morizur, Lise, Lesueur, Léa, Chose, Olivier, Gepp, Michael M., Schulz, André, Neubauer, Julia C., Zimmermann, Heiko, Abranches, Elsa, Man, Jennifer, O’Shea, Orla, Stacey, Glyn, Hewitt, Zoe, Williams, David J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954896/
https://www.ncbi.nlm.nih.gov/pubmed/31983799
http://dx.doi.org/10.1007/s00170-019-04516-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954896/
https://www.ncbi.nlm.nih.gov/pubmed/31983799
http://dx.doi.org/10.1007/s00170-019-04516-1

Ejemplares similares